Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Naiyer A Rizvi, Matthew D Hellmann, +21 authors, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho, Martin L Miller, Natasha Rekhtman, Andre L Moreira, Fawzia Ibrahim, Cameron Bruggeman, Billel Gasmi, Roberta Zappasodi, Yuka Maeda, Chris Sander, Edward B Garon, Taha Merghoub, Jedd D Wolchok, Ton N Schumacher, Timothy A Chan. less Science, 2015 Mar 15; 348(6230). PMID: 25765070 Free PMC article. Highly Cited.
|
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Roy S Herbst, Paul Baas, +16 authors, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn, Margarita Majem, Mary J Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled-Filhart, Edward B Garon. less Lancet, 2015 Dec 30; 387(10027). PMID: 26712084 Highly Cited.
|
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Mark J Selby, John J Engelhardt, +4 authors, Michael Quigley, Karla A Henning, Timothy Chen, Mohan Srinivasan, Alan J Korman. less Cancer Immunol Res, 2014 Apr 30; 1(1). PMID: 24777248 Highly Cited.
|
Immune Checkpoint Blockade in Cancer Therapy. Michael A Postow, Margaret K Callahan, Jedd D Wolchok. J Clin Oncol, 2015 Jan 22; 33(17). PMID: 25605845 Free PMC article. Highly Cited. Review.
|
Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade? Fei Tang, Xuexiang Du, +2 authors, Mingyue Liu, Pan Zheng, Yang Liu. less Cell Biosci, 2018 May 02; 8. PMID: 29713453 Free PMC article.
|
Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Rajeev K Shrimali, Zhiya Yu, +3 authors, Marc R Theoret, Dhanalakshmi Chinnasamy, Nicholas P Restifo, Steven A Rosenberg. less Cancer Res, 2010 Jul 16; 70(15). PMID: 20631075 Free PMC article. Highly Cited.
|
ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization. Andrew S Williams, Wenda Greer, +3 authors, Drew Bethune, Kenneth J Craddock, Gordon Flowerdew, Zhaolin Xu. less Virchows Arch, 2016 Oct 28; 469(5). PMID: 27562706
|
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. Corey J Langer, Shirish M Gadgeel, +17 authors, Hossein Borghaei, Vassiliki A Papadimitrakopoulou, Amita Patnaik, Steven F Powell, Ryan D Gentzler, Renato G Martins, James P Stevenson, Shadia I Jalal, Amit Panwalkar, James Chih-Hsin Yang, Matthew Gubens, Lecia V Sequist, Mark M Awad, Joseph Fiore, Yang Ge, Harry Raftopoulos, Leena Gandhi, KEYNOTE-021 investigators. less Lancet Oncol, 2016 Oct 18; 17(11). PMID: 27745820 Free PMC article. Highly Cited.
|
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. Leena Gandhi, Delvys Rodríguez-Abreu, +27 authors, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell, Susanna Y-S Cheng, Helge G Bischoff, Nir Peled, Francesco Grossi, Ross R Jennens, Martin Reck, Rina Hui, Edward B Garon, Michael Boyer, Belén Rubio-Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M Catherine Pietanza, Marina C Garassino, KEYNOTE-189 Investigators. less N Engl J Med, 2018 Apr 17; 378(22). PMID: 29658856 Highly Cited.
|
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. Tyler R Simpson, Fubin Li, +11 authors, Welby Montalvo-Ortiz, Manuel A Sepulveda, Katharina Bergerhoff, Frederick Arce, Claire Roddie, Jake Y Henry, Hideo Yagita, Jedd D Wolchok, Karl S Peggs, Jeffrey V Ravetch, James P Allison, Sergio A Quezada. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981 Free PMC article. Highly Cited.
|
PD-L1 expression testing in non-small cell lung cancer. Cristina Teixidó, Noelia Vilariño, Roxana Reyes, Noemí Reguart. Ther Adv Med Oncol, 2018 Apr 18; 10. PMID: 29662547 Free PMC article. Highly Cited. Review.
|
Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer. Marta Salido, Lara Pijuan, +13 authors, Luz Martínez-Avilés, Ana B Galván, Israel Cañadas, Ana Rovira, Montserrat Zanui, Alejandro Martínez, Raquel Longarón, Francisco Sole, Sergio Serrano, Beatriz Bellosillo, Murry W Wynes, Joan Albanell, Fred R Hirsch, Edurne Arriola. less J Thorac Oncol, 2010 Nov 26; 6(1). PMID: 21107285 Free PMC article.
|
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC. Mark A Socinski, Robert M Jotte, +18 authors, Federico Cappuzzo, Francisco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez-Abreu, Denis Moro-Sibilot, Christian A Thomas, Fabrice Barlesi, Gene Finley, Claudia Kelsch, Anthony Lee, Shelley Coleman, Yu Deng, Yijing Shen, Marcin Kowanetz, Ariel Lopez-Chavez, Alan Sandler, Martin Reck, IMpower150 Study Group. less N Engl J Med, 2018 Jun 05; 378(24). PMID: 29863955 Highly Cited.
|
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Matthew D Hellmann, Naiyer A Rizvi, +14 authors, Jonathan W Goldman, Scott N Gettinger, Hossein Borghaei, Julie R Brahmer, Neal E Ready, David E Gerber, Laura Q Chow, Rosalyn A Juergens, Frances A Shepherd, Scott A Laurie, William J Geese, Shruti Agrawal, Tina C Young, Xuemei Li, Scott J Antonia. less Lancet Oncol, 2016 Dec 10; 18(1). PMID: 27932067 Free PMC article. Highly Cited.
|
Comparative outcomes of squamous and non-squamous non-small cell lung cancer (NSCLC) patients in phase II studies of ASA404 (DMXAA) - retrospective analysis of pooled data. Mark J McKeage, Michael B Jameson, AS1404-201 Study Group Investigators. J Thorac Dis, 2012 Jan 21; 2(4). PMID: 22263047 Free PMC article.
|
Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway. Parisa Momtaz, Michael A Postow. Pharmgenomics Pers Med, 2014 Dec 09; 7. PMID: 25484597 Free PMC article. Review.
|
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer. Luis Paz-Ares, Alexander Luft, +20 authors, David Vicente, Ali Tafreshi, Mahmut Gümüş, Julien Mazières, Barbara Hermes, Filiz Çay Şenler, Tibor Csőszi, Andrea Fülöp, Jerónimo Rodríguez-Cid, Jonathan Wilson, Shunichi Sugawara, Terufumi Kato, Ki Hyeong Lee, Ying Cheng, Silvia Novello, Balazs Halmos, Xiaodong Li, Gregory M Lubiniecki, Bilal Piperdi, Dariusz M Kowalski, KEYNOTE-407 Investigators. less N Engl J Med, 2018 Oct 04; 379(21). PMID: 30280635 Highly Cited.
|
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. Robbert G van der Most, Andrew J Currie, +5 authors, Sathish Mahendran, Amy Prosser, Anna Darabi, Bruce W S Robinson, Anna K Nowak, Richard A Lake. less Cancer Immunol Immunother, 2008 Dec 05; 58(8). PMID: 19052741
|
Lung cancer. W D Travis, L B Travis, S S Devesa. Cancer, 1995 Jan 01; 75(1 Suppl). PMID: 8000996 Highly Cited.
|
Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Laurence Zitvogel, Lorenzo Galluzzi, Mark J Smyth, Guido Kroemer. Immunity, 2013 Jul 31; 39(1). PMID: 23890065 Highly Cited. Review.
|
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. Yannick Bulliard, Rose Jolicoeur, +6 authors, Maurice Windman, Sarah M Rue, Seth Ettenberg, Deborah A Knee, Nicholas S Wilson, Glenn Dranoff, Jennifer L Brogdon. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897982 Free PMC article. Highly Cited.
|
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. Martin Reck, Delvys Rodríguez-Abreu, +16 authors, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe, Mary O'Brien, Suman Rao, Katsuyuki Hotta, Melanie A Leiby, Gregory M Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R Brahmer, KEYNOTE-024 Investigators. less N Engl J Med, 2016 Oct 11; 375(19). PMID: 27718847 Highly Cited.
|
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. S Novello, F Barlesi, +11 authors, R Califano, T Cufer, S Ekman, M Giaj Levra, K Kerr, S Popat, M Reck, S Senan, G V Simo, J Vansteenkiste, S Peters, ESMO Guidelines Committee. less Ann Oncol, 2016 Sep 25; 27(suppl 5). PMID: 27664245 Highly Cited.
|
Immuno-oncology combinations: raising the tail of the survival curve. Samuel J Harris, Jessica Brown, Juanita Lopez, Timothy A Yap. Cancer Biol Med, 2016 Jul 28; 13(2). PMID: 27458526 Free PMC article.
|
Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Ping Zhang, Dong-Ming Su, Mei Liang, Jian Fu. Mol Immunol, 2007 Oct 09; 45(5). PMID: 17920123
|
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Achim Rittmeyer, Fabrice Barlesi, +23 authors, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M Gadgeel, Toyoaki Hida, Dariusz M Kowalski, Manuel Cobo Dols, Diego L Cortinovis, Joseph Leach, Jonathan Polikoff, Carlos Barrios, Fairooz Kabbinavar, Osvaldo Arén Frontera, Filippo De Marinis, Hande Turna, Jong-Seok Lee, Marcus Ballinger, Marcin Kowanetz, Pei He, Daniel S Chen, Alan Sandler, David R Gandara, OAK Study Group. less Lancet, 2016 Dec 17; 389(10066). PMID: 27979383 Free PMC article. Highly Cited.
|
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI? Gonzalo Recondo, Francesco Facchinetti, +2 authors, Ken A Olaussen, Benjamin Besse, Luc Friboulet. less Nat Rev Clin Oncol, 2018 Aug 16; 15(11). PMID: 30108370 Highly Cited. Review.
|
Pembrolizumab for the treatment of non-small-cell lung cancer. Edward B Garon, Naiyer A Rizvi, +25 authors, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn, Enric Carcereny, Myung-Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D Hellmann, Omid Hamid, Jonathan W Goldman, Jean-Charles Soria, Marisa Dolled-Filhart, Ruth Z Rutledge, Jin Zhang, Jared K Lunceford, Reshma Rangwala, Gregory M Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi, KEYNOTE-001 Investigators. less N Engl J Med, 2015 Apr 22; 372(21). PMID: 25891174 Highly Cited.
|
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advanced Non-Small Cell Lung Cancer (CheckMate 370). David R Spigel, Craig Reynolds, +9 authors, David Waterhouse, Edward B Garon, Jason Chandler, Sunil Babu, Paul Thurmes, Alexander Spira, Robert Jotte, Jin Zhu, Wen Hong Lin, George Blumenschein. less J Thorac Oncol, 2018 Mar 09; 13(5). PMID: 29518553 Highly Cited.
|
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. Liufu Deng, Hua Liang, +4 authors, Byron Burnette, Michael Beckett, Thomas Darga, Ralph R Weichselbaum, Yang-Xin Fu. less J Clin Invest, 2014 Jan 03; 124(2). PMID: 24382348 Free PMC article. Highly Cited.
|
Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors. Vera Hirsh. Ther Adv Med Oncol, 2018 Feb 01; 10. PMID: 29383041 Free PMC article. Review.
|
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. Hossein Borghaei, Luis Paz-Ares, +25 authors, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado, Fabrice Barlesi, Martin Kohlhäufl, Oscar Arrieta, Marco Angelo Burgio, Jérôme Fayette, Hervé Lena, Elena Poddubskaya, David E Gerber, Scott N Gettinger, Charles M Rudin, Naiyer Rizvi, Lucio Crinò, George R Blumenschein, Scott J Antonia, Cécile Dorange, Christopher T Harbison, Friedrich Graf Finckenstein, Julie R Brahmer. less N Engl J Med, 2015 Sep 29; 373(17). PMID: 26412456 Free PMC article. Highly Cited.
|
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study. Scott Antonia, Sarah B Goldberg, +8 authors, Ani Balmanoukian, Jamie E Chaft, Rachel E Sanborn, Ashok Gupta, Rajesh Narwal, Keith Steele, Yu Gu, Joyson J Karakunnel, Naiyer A Rizvi. less Lancet Oncol, 2016 Feb 10; 17(3). PMID: 26858122 Free PMC article. Highly Cited.
|
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. Scott J Antonia, Augusto Villegas, +31 authors, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit, Byoung C Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young-Chul Kim, Christos S Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E Gray, Luis Paz-Ares, Javier de Castro Carpeño, Corinne Faivre-Finn, Martin Reck, Johan Vansteenkiste, David R Spigel, Catherine Wadsworth, Giovanni Melillo, Maria Taboada, Phillip A Dennis, Mustafa Özgüroğlu, PACIFIC Investigators. less N Engl J Med, 2018 Oct 04; 379(24). PMID: 30280658 Highly Cited.
|
Genomic profile, smoking, and response to anti-PD-1 therapy in non-small cell lung carcinoma. Matthew Hellmann, Naiyer Rizvi, Jedd D Wolchok, Timothy A Chan. Mol Cell Oncol, 2016 Jun 17; 3(1). PMID: 27308563 Free PMC article.
|
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. Matthew D Hellmann, Tudor-Eliade Ciuleanu, +21 authors, Adam Pluzanski, Jong Seok Lee, Gregory A Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak Burgers, Pamela Salman, Hossein Borghaei, Suresh S Ramalingam, Julie Brahmer, Martin Reck, Kenneth J O'Byrne, William J Geese, George Green, Han Chang, Joseph Szustakowski, Prabhu Bhagavatheeswaran, Diane Healey, Yali Fu, Faith Nathan, Luis Paz-Ares. less N Engl J Med, 2018 Apr 17; 378(22). PMID: 29658845 Free PMC article. Highly Cited.
|
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Razvan Cristescu, Robin Mogg, +21 authors, Mark Ayers, Andrew Albright, Erin Murphy, Jennifer Yearley, Xinwei Sher, Xiao Qiao Liu, Hongchao Lu, Michael Nebozhyn, Chunsheng Zhang, Jared K Lunceford, Andrew Joe, Jonathan Cheng, Andrea L Webber, Nageatte Ibrahim, Elizabeth R Plimack, Patrick A Ott, Tanguy Y Seiwert, Antoni Ribas, Terrill K McClanahan, Joanne E Tomassini, Andrey Loboda, David Kaufman. less Science, 2018 Oct 13; 362(6411). PMID: 30309915 Free PMC article. Highly Cited.
|
Biomarkers for immune checkpoint inhibitors in advanced nonsmall cell lung cancer. Robert Pirker. Curr Opin Oncol, 2018 Nov 13; 31(1). PMID: 30418192 Review.
|
Immunotherapeutic properties of chemotherapy. Carole Fournier, Thaiz Rivera Vargas, +2 authors, Tiffany Martin, Andréa Melis, Lionel Apetoh. less Curr Opin Pharmacol, 2017 May 30; 35. PMID: 28551360 Review.
|
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Nasser Hanna, David Johnson, +14 authors, Sarah Temin, Sherman Baker, Julie Brahmer, Peter M Ellis, Giuseppe Giaccone, Paul J Hesketh, Ishmael Jaiyesimi, Natasha B Leighl, Gregory J Riely, Joan H Schiller, Bryan J Schneider, Thomas J Smith, Joan Tashbar, William A Biermann, Gregory Masters. less J Clin Oncol, 2017 Aug 15; 35(30). PMID: 28806116 Highly Cited.
|
Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody. Ross Stewart, Michelle Morrow, +18 authors, Scott A Hammond, Kathy Mulgrew, Danielle Marcus, Edmund Poon, Amanda Watkins, Stefanie Mullins, Matthieu Chodorge, John Andrews, David Bannister, Emily Dick, Nicola Crawford, Julie Parmentier, Marat Alimzhanov, John S Babcook, Ian N Foltz, Andrew Buchanan, Vahe Bedian, Robert W Wilkinson, Matthew McCourt. less Cancer Immunol Res, 2015 May 07; 3(9). PMID: 25943534 Highly Cited.
|
Immunologic and clinical effects of targeting PD-1 in lung cancer. R D Harvey. Clin Pharmacol Ther, 2014 Apr 03; 96(2). PMID: 24690569 Free PMC article. Review.
|
External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Mala Chakraborty, Scott I Abrams, +3 authors, C Norman Coleman, Kevin Camphausen, Jeffrey Schlom, James W Hodge. less Cancer Res, 2004 Jun 19; 64(12). PMID: 15205348 Highly Cited.
|
The blockade of immune checkpoints in cancer immunotherapy. Drew M Pardoll. Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437870 Free PMC article. Highly Cited. Review.
|
Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. Simon J Dovedi, Amy L Adlard, +11 authors, Grazyna Lipowska-Bhalla, Conor McKenna, Sherrie Jones, Eleanor J Cheadle, Ian J Stratford, Edmund Poon, Michelle Morrow, Ross Stewart, Hazel Jones, Robert W Wilkinson, Jamie Honeychurch, Tim M Illidge. less Cancer Res, 2014 Oct 03; 74(19). PMID: 25274032 Highly Cited.
|
Lung cancer. Roy S Herbst, John V Heymach, Scott M Lippman. N Engl J Med, 2008 Sep 26; 359(13). PMID: 18815398 Highly Cited. Review.
|
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. Julie Brahmer, Karen L Reckamp, +22 authors, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado, David Waterhouse, Neal Ready, Justin Gainor, Osvaldo Arén Frontera, Libor Havel, Martin Steins, Marina C Garassino, Joachim G Aerts, Manuel Domine, Luis Paz-Ares, Martin Reck, Christine Baudelet, Christopher T Harbison, Brian Lestini, David R Spigel. less N Engl J Med, 2015 Jun 02; 373(2). PMID: 26028407 Free PMC article. Highly Cited.
|
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. David S Ettinger, Douglas E Wood, +32 authors, Dara L Aisner, Wallace Akerley, Jessica Bauman, Lucian R Chirieac, Thomas A D'Amico, Malcolm M DeCamp, Thomas J Dilling, Michael Dobelbower, Robert C Doebele, Ramaswamy Govindan, Matthew A Gubens, Mark Hennon, Leora Horn, Ritsuko Komaki, Rudy P Lackner, Michael Lanuti, Ticiana A Leal, Leah J Leisch, Rogerio Lilenbaum, Jules Lin, Billy W Loo, Renato Martins, Gregory A Otterson, Karen Reckamp, Gregory J Riely, Steven E Schild, Theresa A Shapiro, James Stevenson, Scott J Swanson, Kurt Tauer, Stephen C Yang, Kristina Gregory, Miranda Hughes. less J Natl Compr Canc Netw, 2017 Apr 14; 15(4). PMID: 28404761 Highly Cited.
|
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Bryan A Chan, Brett G M Hughes. Transl Lung Cancer Res, 2015 Mar 26; 4(1). PMID: 25806345 Free PMC article. Highly Cited. Review.
|
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Freddie Bray, Jacques Ferlay, +3 authors, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. less CA Cancer J Clin, 2018 Sep 13; 68(6). PMID: 30207593 Highly Cited.
|
CTLA-4 blockade in tumor models: an overview of preclinical and translational research. Joseph F Grosso, Maria N Jure-Kunkel. Cancer Immun, 2013 Feb 08; 13. PMID: 23390376 Free PMC article. Highly Cited. Review.
|
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. Eric A Reits, James W Hodge, +14 authors, Carla A Herberts, Tom A Groothuis, Mala Chakraborty, Elizabeth K Wansley, Kevin Camphausen, Rosalie M Luiten, Arnold H de Ru, Joost Neijssen, Alexander Griekspoor, Elly Mesman, Frank A Verreck, Hergen Spits, Jeffrey Schlom, Peter van Veelen, Jacques J Neefjes. less J Exp Med, 2006 Apr 26; 203(5). PMID: 16636135 Free PMC article. Highly Cited.
|
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics. Ting-Yuan David Cheng, Susanna M Cramb, +3 authors, Peter D Baade, Danny R Youlden, Chukwumere Nwogu, Mary E Reid. less J Thorac Oncol, 2016 Jul 02; 11(10). PMID: 27364315 Free PMC article. Highly Cited.
|
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. Amit A Lugade, James P Moran, +3 authors, Scott A Gerber, Robert C Rose, John G Frelinger, Edith M Lord. less J Immunol, 2005 Jun 10; 174(12). PMID: 15944250 Highly Cited.
|
Enhancement of antitumor immunity by CTLA-4 blockade. D R Leach, M F Krummel, J P Allison. Science, 1996 Mar 22; 271(5256). PMID: 8596936 Highly Cited.
|